Mkts

agilon health, inc.

NYSE: AGL
$113.52-0.50 (-0.44%)
As of Nov 10, 4:00 PM ET

Key statistics

Day range
110.10114.26
52-week range
7.48133.04
Today
Open111.64
Previous close113.52
Volume—
Valuation
Market cap1.91B
P/E ratio—
EPS (TTM)-14.06
Income & risk
Dividend / yield—
Beta3.04
Avg volume271.9K
Discussion

AGL News

Stories mentioning AGL from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue1,420,4601,569,4911,435,3211,394,9821,532,7821,522,4861,450,9321,482,758
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)3,997(193,825)(131,274)(116,027)(22,110)(108,100)(133,508)(43,344)
Interest Income
Interest Expense
Other Expense
Pretax Income29,944(187,558)(110,538)(104,308)(1,692)(104,673)(117,022)(30,245)
Tax Provision28.001,324(331.00)62.00196.001,757(590.00)417.00
Net Income (Loss)48,916(188,882)(110,207)(104,370)12,112(105,790)(117,615)(30,682)
Earnings Per Share (Basic)2.95(0.46)0.73(0.26)
Earnings Per Share (Diluted)2.94(0.46)0.73(0.26)
Weighted Average Shares Outstanding (Basic)16,599413,969414,465413,83616,517410,966411,591411,271
Weighted Average Shares Outstanding (Diluted)16,662413,969414,465413,83616,517410,966411,591411,271

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About AGL

agilon health, inc. (NYSE: AGL) is a stock listed on the New York Stock Exchange under the ticker symbol AGL. It last traded at $113.52 (Nov 10, 2026, 4:00 PM ET), down 0.4% on the day. That gives agilon health a market capitalisation of $1.9B.

Over the past 52 weeks AGL has traded between $7.48 and $133.04.

Revenue for the quarter ended Mar 31, 2026 was $1.4B; net income $48.9M. Revenue was down 7.3% from $1.5B in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$1.4B$48.9M3.4%
Dec 31, 2025$1.6B-$188.9M-12.0%
Sep 30, 2025$1.4B-$110.2M-7.7%
Jun 30, 2025$1.4B-$104.4M-7.5%

From agilon health’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…